OXANDROLONOS

$ 74

Category: Brand:

Description

Chemical name: 17α-Methyl-17β-hydroxy-2-oxa-[5α]-androstan-3-one Formula: C19H30O3 Anabolic activity index: 400 % Androgenic activity index: 24 % OXANDROLONOS – PHARMACOM LABS 100 TABS X 10 MG Shipping Information Currently, orders from our International Premium Warehouse 1 can be shipped to continental United States only . Temporary shipping restrictions apply to Hawaii and Alaska. Military addresses (including APO, FPO, etc.) are currently not supported. PO Box deliveries are available exclusively through our domestic warehouse (USA Warehouse 1). Oxandrolone, commonly known as Anavar, is an oral 17-alpha-alkylated steroid and a modification of dihydrotestosterone. Initially developed for the treatment of conditions such as debilitated HIV-infected patients, Turner syndrome, anaemia, and for enhancing bone strength and recovery from burns. Benefits: Does not undergo aromatization and is non-estrogenic. Preferred by athletes preparing for strength and endurance competitions, emphasizing lean muscle development without water retention and fat accumulation. Ideal for achieving a more defined and relief appearance. While not conducive to significant muscle volume gains, it excels in fat reduction. Side Effects: Minimal hepatotoxic impact on the liver despite being 17-alpha-alkylated. Research indicates that a 20 mg per day oxandrolone cycle for twelve weeks did not statistically elevate AST and ALT levels. Rare occurrence of side effects, making oxandrolone one of the mildest and safest oral steroids available for sale. Oxandrolone results may not be as pronounced compared to other steroids. Dosage Instructions: Recommended daily dosage: 20 mg. Cycle duration: Twelve weeks. Considered suitable for individuals new to anabolic steroids due to its mild and safe nature. Ideal for those seeking a balance between performance enhancement and minimal risk of side effects.

Reviews

There are no reviews yet.

Be the first to review “OXANDROLONOS”

Your email address will not be published. Required fields are marked *